Ivabenor contains ivabradine. It mainly works by reducing the heart rate by a few beats per minute. This lowers the heart’s need for oxygen especially in situations when an angina attack is more likely to happen. Ivabenor thereby helps to control and reduce the number of angina attacks.


Symptomatic treatment of chronic stable angina pectoris
Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease in adults with normal sinus rhythm and heart rate ≥ 70 bpm.
Ivabradine is indicated:
– in adults unable to tolerate or with a contraindication to the use of beta-blockers;
– in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.

Treatment of chronic heart failure
Ivabradine is indicated in chronic heart failure II to IV class (according to NYHA classification) with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Subject to medical prescription.

Concentration and pharmaceutical form: 5 mg, 7.5 mg film-coated tablets